SUNDAY, JUNE 24, 2018

Nanoly Bioscience and CU-Boulder team up for vaccine stabilization

Nanoly Science of Boulder and the University of Colorado recently signed an option agreement to develop a technique to protect vaccines during delivery to rural and less-developed locations.

A team led by Kristi Anseth, a professor with the university's chemical and biological engineering department, developed a unique material that is being adapted to protect the vaccines. The nano-polymer material can be blended with vaccines to protect against thermal damage during transportation and improve vaccine availability in remote areas.

"We are excited that Nanoly has optioned Dr. Anseth's polymer technology," MaryBeth Vellequette, the director of technology transfer for CU-Boulder, said. "Nanoly has a very dynamic team that is passionate about developing this technology and we are eager to continue working with them as this venture grows."

Many vaccines needed in developing countries to protect against diseases like polio, diphtheria, pertussis, tetanus and measles, must be kept between 35 degrees Fahrenheit and 45 degrees Fahrenheit during delivery, transportation and storage. When vaccines go outside of the temperature range, they can become degraded and ineffective. Maintaining the cold chain is a serious issue in remote areas where electricity is unreliable or absent.

"We're thrilled to be adapting CU technology and working toward a solution for such an important problem," Balaji Sridhar, a co-founder of Nanoly, said.